Related Experiment Video
Updated: Feb 27, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
Apolipoprotein E Polymorphism and Left Ventricular Failure in Beta-Thalassemia: A Multivariate Meta-Analysis.
Niki L Dimou1, Katerina G Pantavou1, Pantelis G Bagos1
1Department of Computer Science and Biomedical Informatics, University of Thessaly, Papasiopoulou 2-4, Lamia, 35100, Greece.
Apolipoprotein E (ApoE) E4 allele is a genetic risk factor for left ventricular failure (LVF) in beta-thalassemia major patients. This finding emerged from a multivariate meta-analysis of independent studies.
Area of Science:
- Genetics
- Cardiology
- Hematology
Background:
- Left ventricular failure (LVF) is a major cause of mortality in beta-thalassemia homozygotes.
- Apolipoprotein E (ApoE) is a potential genetic risk factor for LVF.
Purpose of the Study:
- To synthesize results from independent studies on the effect of ApoE on LVF development in thalassemic patients using a meta-analytic approach.
- To develop and apply a multivariate meta-analytic method for simultaneous analysis of multiple exposures and comparison groups.
Main Methods:
- A multivariate meta-analytic approach was developed to account for multiple outcomes and genetic polymorphisms.
- Four independent studies involving 613 beta-thalassemic patients and 664 controls were included.
- The method considered the correlation of log odds ratios (log(ORs)).
Main Results:
- A statistically significant overall association between ApoE and LVF was found (P-value = 0.009).
- The E4 allele showed a significant association with LVF compared to the E3 allele.
- Specifically, E4 was linked to LVF in patients with clinical and echocardiographic findings (OR: 3.34, 95% CI: 1.78, 6.26).
Conclusions:
- The ApoE E4 allele is a significant genetic risk factor for LVF in beta-thalassemia major.
- The developed multivariate meta-analytic approach is robust and applicable to various research fields.
More Related Videos
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Multiple Allele Traits
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Heart Failure II: Pathophysiology